CaCP29
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CaCP29, covering 2012-01-13 to 2012-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29 [Phase 1]